Barbara A. Bopp

695 total citations
19 papers, 494 citations indexed

About

Barbara A. Bopp is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Barbara A. Bopp has authored 19 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Barbara A. Bopp's work include Analytical Chemistry and Chromatography (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Barbara A. Bopp is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Barbara A. Bopp collaborates with scholars based in United States and United Kingdom. Barbara A. Bopp's co-authors include J. W. Kesterson, Hollis D. Kleinert, Robert C. Sonders, A. G. Renwick, Jay R. Luly, Herman H. Stein, Patrick A. Marcotte, Anthony K. L. Fung, John H. Biel and Jacob J. Plattner and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Life Sciences.

In The Last Decade

Barbara A. Bopp

19 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara A. Bopp United States 12 188 104 89 69 61 19 494
James A. Oppermann United States 11 100 0.5× 32 0.3× 100 1.1× 54 0.8× 31 0.5× 17 495
Lan K. Wong United States 13 175 0.9× 81 0.8× 33 0.4× 54 0.8× 41 0.7× 44 638
Tetsuo Adachi Japan 11 175 0.9× 29 0.3× 52 0.6× 38 0.6× 12 0.2× 25 399
Donald R. Van Harken United States 13 193 1.0× 20 0.2× 64 0.7× 26 0.4× 135 2.2× 22 631
Masafumi Hisaoka Japan 13 121 0.6× 43 0.4× 34 0.4× 33 0.5× 23 0.4× 28 404
Richard Czerniak United States 9 189 1.0× 185 1.8× 10 0.1× 40 0.6× 32 0.5× 18 529
Morris Pfeffer United States 14 97 0.5× 38 0.4× 14 0.2× 51 0.7× 66 1.1× 20 634
Ben J. van der Walt South Africa 14 150 0.8× 43 0.4× 27 0.3× 9 0.1× 74 1.2× 25 564
Lin‐Chau Chang Taiwan 12 201 1.1× 46 0.4× 28 0.3× 42 0.6× 94 1.5× 30 634
A. V. Marton Canada 10 173 0.9× 22 0.2× 23 0.3× 20 0.3× 23 0.4× 20 439

Countries citing papers authored by Barbara A. Bopp

Since Specialization
Citations

This map shows the geographic impact of Barbara A. Bopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Bopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Bopp more than expected).

Fields of papers citing papers by Barbara A. Bopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Bopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Bopp. The network helps show where Barbara A. Bopp may publish in the future.

Co-authorship network of co-authors of Barbara A. Bopp

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Bopp. A scholar is included among the top collaborators of Barbara A. Bopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Bopp. Barbara A. Bopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bopp, Barbara A.. (1998). A Research Guide for Undergraduate Students: English and American Literature. Nancy L. Baker, Nancy Huling. The Library Quarterly. 68(2). 238–240. 1 indexed citations
2.
Machinist, Joseph M., Michael Kukulka, & Barbara A. Bopp. (1995). In Vitro Plasma Protein Binding of Zileuton and its N-Dehydroxylated Metabolite. Clinical Pharmacokinetics. 29(Supplement 2). 34–41. 20 indexed citations
3.
Hussein, Ziad, Darcy J. Mulford, Barbara A. Bopp, & G. Richard Granneman. (1993). Stereoselective pharmacokinetics of pazinaclone, a new non‐benzodiazepine anxiolytic, and its active metabolite in healthy subjects. British Journal of Clinical Pharmacology. 36(4). 357–361. 36 indexed citations
4.
Hussein, Ziad, Darcy J. Mulford, Barbara A. Bopp, & G. Richard Granneman. (1993). Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.. Drug Metabolism and Disposition. 21(5). 805–810. 3 indexed citations
5.
Rosenberg, Saul H., Keith W. Woods, Hing L. Sham, et al.. (1990). Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action. Journal of Medicinal Chemistry. 33(7). 1962–1969. 20 indexed citations
6.
Ferrero, J L, Barbara A. Bopp, Kennan C. Marsh, et al.. (1990). Metabolism and disposition of clarithromycin in man.. Drug Metabolism and Disposition. 18(4). 441–446. 97 indexed citations
7.
Kleinert, Hollis D., Jay R. Luly, Barbara A. Bopp, et al.. (1990). Profile of the Renin Inhibitor, Enalkiren (ABBOTT‐64662). Cardiovascular Drug Reviews. 8(3). 203–219. 13 indexed citations
8.
Plattner, Jacob J., Patrick A. Marcotte, Hollis D. Kleinert, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability. Journal of Medicinal Chemistry. 31(12). 2277–2288. 54 indexed citations
9.
Luly, Jay R., Nwe Y. BaMaung, Anthony K. L. Fung, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency. Journal of Medicinal Chemistry. 31(12). 2264–2276. 53 indexed citations
10.
Dellaria, Joseph F., Robert G. Maki, Barbara A. Bopp, et al.. (1987). Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement. Journal of Medicinal Chemistry. 30(11). 2137–2144. 28 indexed citations
11.
Machinist, Joseph M., Barbara A. Bopp, Danielle Anderson, et al.. (1986). Metabolism of14C-estazolam in dogs and humans. Xenobiotica. 16(1). 11–20. 13 indexed citations
12.
Bopp, Barbara A., Robert C. Sonders, J. W. Kesterson, & A. G. Renwick. (1986). Toxicological aspects of cyclamate and cyclohexylamine. PubMed. 16(3). 213–306. 63 indexed citations
13.
Machinist, Joseph M., et al.. (1984). Metabolism of [14C]Cefmenoxime in normal subjects after intramuscular administration. Antimicrobial Agents and Chemotherapy. 26(4). 431–435. 5 indexed citations
14.
Bopp, Barbara A., et al.. (1984). Pharmacokinetics of Fostedil, a new Calcium Antagonist, in Beagle Dogs Following Oral and Intravenous Administration. Journal of Pharmaceutical Sciences. 73(10). 1400–1403. 3 indexed citations
15.
Bopp, Barbara A., et al.. (1982). Metabolic Fate of Selected Selenium Compounds in Laboratory Animals and Man. Drug Metabolism Reviews. 13(2). 271–318. 57 indexed citations
16.
Bopp, Barbara A., et al.. (1982). Intraocular Penetration of Topically Applied [14C]Fosfonet Sodium in Rabbits. Journal of Pharmaceutical Sciences. 71(3). 368–370. 1 indexed citations
17.
Dren, Anthony T., et al.. (1978). Local Anesthetic Activity and Acute Toxicity of N-Substituted 1,2,3,4-Tetrahydro-1- and 2-naphthylamines. Journal of Pharmaceutical Sciences. 67(6). 880–882. 3 indexed citations
18.
Bopp, Barbara A., et al.. (1978). Local Anesthetic Activity and Acute Toxicity of N-Heptyl-1,2,3,4-tetrahydro-6-rnethoxy-1-naphthylamine Methanesulfonate. Journal of Pharmaceutical Sciences. 67(6). 882–884. 2 indexed citations
19.
Bopp, Barbara A. & John H. Biel. (1974). Antidepressant drugs. Life Sciences. 14(3). 415–423. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Oppermann Breakdown of academic impact, for papers by Lan K. Wong Breakdown of academic impact, for papers by Tetsuo Adachi Breakdown of academic impact, for papers by Donald R. Van Harken Breakdown of academic impact, for papers by Masafumi Hisaoka Breakdown of academic impact, for papers by Richard Czerniak Breakdown of academic impact, for papers by Morris Pfeffer Breakdown of academic impact, for papers by Ben J. van der Walt Breakdown of academic impact, for papers by Lin‐Chau Chang Breakdown of academic impact, for papers by A. V. Marton
Rankless by CCL
2026